Citrus Bioflavonoids Market Size & Share, Growth Report 2032

Citrus Bioflavonoids Market Size By Source (Orange, Tangarines, Mandarins, Limes & Lemons, Grapefruit), By Product (Hesperitin, Eriocitrin, Apigenin, Diosmin, Naringin, Narirutin), By Type (Conventional, Organic), Application & Forecast, 2023 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates and working

1.3&nbsp;&nbsp;&nbsp; Forecast calculations.

1.4&nbsp;&nbsp;&nbsp; Region-wise COVID-19 impact analysis:

1.4.1&nbsp;&nbsp;&nbsp; North America

1.4.2&nbsp;&nbsp;&nbsp; Europe

1.4.3&nbsp;&nbsp;&nbsp; APAC

1.4.4&nbsp;&nbsp;&nbsp; MEA

1.4.5&nbsp;&nbsp;&nbsp; LATAM

1.5&nbsp;&nbsp;&nbsp; Data Sources

1.5.1&nbsp;&nbsp;&nbsp; Secondary

1.5.1.1&nbsp;&nbsp;&nbsp;Paid Sources

1.5.1.2&nbsp;&nbsp;&nbsp;Public Sources

1.5.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Citrus Bioflavonoids industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Source Trends.

2.1.3&nbsp;&nbsp;&nbsp; Product Trends.

2.1.4&nbsp;&nbsp;&nbsp; Type Trends.

2.1.5&nbsp;&nbsp;&nbsp; Application Trends.

2.1.6&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Global Citrus Bioflavonoids Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry size &amp; forecast, 2018 &ndash; 2032

3.2.1&nbsp;&nbsp;&nbsp; COVID-19 impact on the industry landscape

3.3&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.3.1&nbsp;&nbsp;&nbsp; Vendor matrix

3.3.2&nbsp;&nbsp;&nbsp; Distribution channel analysis

3.3.2.1&nbsp;&nbsp;&nbsp;Distributors

3.3.3&nbsp;&nbsp;&nbsp; COVID-19 impact on the industry value chain

3.4&nbsp;&nbsp;&nbsp; Raw material analysis

3.4.1&nbsp;&nbsp;&nbsp; Orange

3.4.2&nbsp;&nbsp;&nbsp; Lemon and lime

3.4.3&nbsp;&nbsp;&nbsp; Grapefruit

3.4.4&nbsp;&nbsp;&nbsp; Tangerine

3.4.5&nbsp;&nbsp;&nbsp; Raw material analysis of the COVID-19 impact on supply

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.5.1&nbsp;&nbsp;&nbsp; Hesperidin production process

3.5.2&nbsp;&nbsp;&nbsp; Eriocitrin production process

3.5.3&nbsp;&nbsp;&nbsp; Apigenin production process

3.5.4&nbsp;&nbsp;&nbsp; Diosmin production process

3.5.5&nbsp;&nbsp;&nbsp; Naringin production process

3.5.6&nbsp;&nbsp;&nbsp; Narirutin production process

3.6&nbsp;&nbsp;&nbsp; Cost structure analysis, 2022

3.6.1&nbsp;&nbsp;&nbsp; Citrus bioflavonoids production cost

3.7&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7.1&nbsp;&nbsp;&nbsp; Europe

3.7.2&nbsp;&nbsp;&nbsp; U.S.

3.7.3&nbsp;&nbsp;&nbsp; FDA

3.8&nbsp;&nbsp;&nbsp; Pricing analysis, 2018 &ndash; 2032

3.8.1&nbsp;&nbsp;&nbsp; Citrus Bioflavonoids pricing trends

3.8.1.1&nbsp;&nbsp;&nbsp;Citrus Bioflavonoids price trends

3.8.2&nbsp;&nbsp;&nbsp; COVID Impact on pricing trends

3.9&nbsp;&nbsp;&nbsp; Industry impact forces

3.9.1&nbsp;&nbsp;&nbsp; Growth drivers

3.9.1.1&nbsp;&nbsp;&nbsp;North America: Increasing usage of dietary supplements will drive the citrus bioflavonoid market

3.9.1.2&nbsp;&nbsp;&nbsp;Asia Pacific: Increase in clean-label food consumption promoting citrus bioflavonoid demand

3.9.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.9.2.1&nbsp;&nbsp;&nbsp;Side effects and restrictions

3.10&nbsp;&nbsp;&nbsp; Innovation &amp; sustainability

3.11&nbsp;&nbsp;&nbsp; Growth potential analysis

3.11.1&nbsp;&nbsp;&nbsp; By application

3.11.2&nbsp;&nbsp;&nbsp; Emerging business models

3.11.2.1&nbsp;&nbsp;&nbsp; Acquisitions

3.11.2.2&nbsp;&nbsp;&nbsp; Collaboration/Joint ventures

3.11.2.3&nbsp;&nbsp;&nbsp; New product launches

3.11.2.4&nbsp;&nbsp;&nbsp; Capacity expansion

3.12&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.12.1&nbsp;&nbsp;&nbsp; Bargaining power of suppliers

3.12.2&nbsp;&nbsp;&nbsp; Bargaining power of buyers

3.12.3&nbsp;&nbsp;&nbsp; Threat of new entrants

3.12.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.13&nbsp;&nbsp;&nbsp; PESTEL analysis

3.14&nbsp;&nbsp;&nbsp; COVID-19 Impact on applications

3.14.1&nbsp;&nbsp;&nbsp; Dietary supplements

3.14.2&nbsp;&nbsp;&nbsp; Food &amp; beverages

3.14.3&nbsp;&nbsp;&nbsp; Animal feed

3.14.4&nbsp;&nbsp;&nbsp; Personal care &amp; cosmetics

3.15&nbsp;&nbsp;&nbsp; COVID-19 overview on world economy

3.16&nbsp;&nbsp;&nbsp; Impact of Russia-Ukraine war on citrus bioflavonoids market

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape

4.1&nbsp;&nbsp;&nbsp;Introduction

4.2&nbsp;&nbsp;&nbsp;Company market share analysis, 2022

4.3&nbsp;&nbsp;&nbsp;Competive analysis of key market players, 2022

4.4&nbsp;&nbsp;&nbsp;Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp;Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Citrus Bioflavonoids Market, By Source

5.1&nbsp;&nbsp;&nbsp; Key Source Trends

5.2&nbsp;&nbsp;&nbsp; Orange, tangarines, mandarins

5.3&nbsp;&nbsp;&nbsp; Limes &amp; lemons

5.4&nbsp;&nbsp;&nbsp; Grapefruit

5.5&nbsp;&nbsp;&nbsp; Others

Chapter 6&nbsp;&nbsp;&nbsp;Citrus Bioflavonoids Market, By Product

6.1&nbsp;&nbsp;&nbsp; Key Grade Trends

6.2&nbsp;&nbsp;&nbsp; Hesperetin

6.3&nbsp;&nbsp;&nbsp; Eriocitrin

6.4&nbsp;&nbsp;&nbsp; Apigenin

6.5&nbsp;&nbsp;&nbsp; Diosmin

6.6&nbsp;&nbsp;&nbsp; Naringin

6.7&nbsp;&nbsp;&nbsp; Narirutin

6.8&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Citrus Bioflavonoids Market, By Type

7.1&nbsp;&nbsp;&nbsp; Key Type Trends

7.2&nbsp;&nbsp;&nbsp; Conventional

7.3&nbsp;&nbsp;&nbsp; Organic

Chapter 8&nbsp;&nbsp;&nbsp;Citrus Bioflavonoids Market, By Application

8.1&nbsp;&nbsp;&nbsp; Key Application Trend

8.2&nbsp;&nbsp;&nbsp; Pharmaceuticals &amp; dietary supplements

8.3&nbsp;&nbsp;&nbsp; Food &amp; beverages

8.4&nbsp;&nbsp;&nbsp; Animal feed

8.5&nbsp;&nbsp;&nbsp; Cosmetics &amp; Personal care

Chapter 9&nbsp;&nbsp;&nbsp;Citrus Bioflavonoids Market, By Region

9.1&nbsp;&nbsp;&nbsp; Key regional trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.6&nbsp;&nbsp;&nbsp; U.S.

9.2.7&nbsp;&nbsp;&nbsp; Canada

9.2.8&nbsp;&nbsp;&nbsp; Mexico

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.6&nbsp;&nbsp;&nbsp; Germany

9.3.7&nbsp;&nbsp;&nbsp; UK

9.3.8&nbsp;&nbsp;&nbsp; France

9.3.9&nbsp;&nbsp;&nbsp; Italy

9.3.10&nbsp;&nbsp;&nbsp; Spain

9.3.11&nbsp;&nbsp;&nbsp; Russia

9.3.12&nbsp;&nbsp;&nbsp; Poland

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.6&nbsp;&nbsp;&nbsp; China

9.4.7&nbsp;&nbsp;&nbsp; India

9.4.8&nbsp;&nbsp;&nbsp; Japan

9.4.9&nbsp;&nbsp;&nbsp; Australia

9.4.10&nbsp;&nbsp;&nbsp; South Korea

9.4.11&nbsp;&nbsp;&nbsp; Thailand

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.6&nbsp;&nbsp;&nbsp; Brazil

9.6&nbsp;&nbsp;&nbsp; MEA

9.6.6&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.7&nbsp;&nbsp;&nbsp; UAE

9.6.8&nbsp;&nbsp;&nbsp; South Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Ingredients by Nature (IBN)

10.2&nbsp;&nbsp;&nbsp; Freeda Vitamins Inc

10.3&nbsp;&nbsp;&nbsp; Solgar Inc.

10.4&nbsp;&nbsp;&nbsp; Organika Health Products Inc. (Organika)

10.5&nbsp;&nbsp;&nbsp; Natural Factors Inc

10.6&nbsp;&nbsp;&nbsp; NOW Foods, Inc.

10.7&nbsp;&nbsp;&nbsp; Country Life LLC

10.8&nbsp;&nbsp;&nbsp; Cayman Chemical Company Incorporated

10.9&nbsp;&nbsp;&nbsp; Merck KGaA

10.10&nbsp;&nbsp;&nbsp; Nans Products

10.11&nbsp;&nbsp;&nbsp; Shaanxi Kingsci Biotechnology Co., Ltd

10.12&nbsp;&nbsp;&nbsp; BOC Sciences

10.13&nbsp;&nbsp;&nbsp; Santa Cruz Biotechnology, Inc

10.15&nbsp;&nbsp;&nbsp; NutraCap Labs, LLC

10.16&nbsp;&nbsp;&nbsp; Hunan Yuantong Pharmaceutical Co., Ltd

10.17&nbsp;&nbsp;&nbsp; Yaan Times Biotech

10.18&nbsp;&nbsp;&nbsp; Destilaciones Bordas Chinchurreta S.A

10.19&nbsp;&nbsp;&nbsp; Hunan Sunfull Bio-tech Co., Ltd

10.20&nbsp;&nbsp;&nbsp; MORRE-TEC Industries, Inc. 
&nbsp;

Citrus Bioflavonoids Market

Get a free sample of this report